SCHEMBL14770639

SCHEMBL14770639

c1ccc2c(c1)c1ccccc1n2-c1ccnc(-c2cc(-c3ccc4oc5ccc(-n6c7ccccc7c7ccccc76)cc5c4c3)ccn2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
NPC1 O15118 2/20 0.33
MAPT P10636 2/20 0.33
PRKDC P78527 2/20 0.33
PTPN1 P18031 4/20 0.32
PTPRF P10586 3/20 0.32
PTPN2 P17706 3/20 0.32
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PLA2G2A P14555 2/20 0.30
PLA2G4A P47712 2/20 0.30
CHEK2 O96017 1/20 0.30
CASP3 P42574 1/20 0.30
SENP7 Q9BQF6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14770641 0.95 NPC1 (0.39) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL10041344 0.94 KDM4E (0.35) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL14770703 0.93 KDM4E (0.36) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL14770632 0.89 PTPRF (0.33) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL14770643 0.88 NPC1 (0.32) NPC1MAPTPTPN1PTPRFPTPN2
SCHEMBL14770705 0.86 PDE4A (0.35) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL14770644 0.86 ALOX5 (0.44) NPC1MAPTPRKDCPTPN1PTPRF
SCHEMBL15780991 0.85 KDM4E (0.46) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL280420 0.85 KDM4E (0.46) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL2628401 0.85 KDM4E (0.46) KDM4EATML3MBTL1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L KDM4E 1763/4885ATM 1105/4885L3MBTL1 3163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.